Lamin B2 regulates nuclear remodeling in cardiomyocyte terminal differentiation

Lamin B2 调节心肌细胞终末分化中的核重塑

基本信息

  • 批准号:
    10579284
  • 负责人:
  • 金额:
    $ 32.76万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-04-01 至 2024-01-31
  • 项目状态:
    已结题

项目摘要

ABSTRACT Heart disease is the leading cause of morbidity and mortality worldwide. Different types of heart injury lead to the development of heart failure, a chronically progressive disease. Heart failure is characterized by increased cardiomyocyte death and insufficient regeneration of new ones. As such, increasing cardiomyocyte regeneration and decreasing death represent targets for new therapies. This application is for developing a transformative paradigm connecting these important cellular mechanisms with nuclear remodeling in cardiomyocyte differentiation. Our new results show that when cardiomyocytes differentiate they decrease the number of nuclear pores (NP). NP are large channels of > 100 nm outer diameter for communication between the nucleus and the cytoplasm. NP, along with the nuclear lamina (NL), function in regulating the nuclear transport of signaling molecules and chromatin organization. Although heart failure alters nuclear transport, the structural and functional changes of NL and NP changes during terminal differentiation are unknown. To determine the molecular mechanisms directing the decrease of NP, we have used single-cell transcriptional profiling, which identified a decrease in expression of lamin B2 (Lmnb2), an intermediate filament and component of the NL, during cardiomyocyte differentiation. Our new results show that Lmnb2 gene knockout in cardiomyocytes blocks M-phase, that is, nuclei do not divide, and instead become polyploid. In addition, the M-phase block decreases NP incorporation. As a result, although the DNA contents of nuclei (ploidy) increases, the number of NP decreases by 50%. The lower NP number identifies a central event in nuclear remodeling, as it indicates not only altered nuclear transport, but also altered chromatin structure. Together, this could explain the decreased ability of terminally differentiated cardiomyocytes to activate cell cycle genes and their increased susceptibility to cell death. This proposal aims to develop a new mechanistic paradigm of nuclear remodeling in cardiomyocyte differentiation, which is synergistic with recent advances in characterizing chromatin changes. We will test the central hypothesis that decreased Lmnb2 gene expression is a central mechanism of nuclear remodeling in cardiomyocyte differentiation. We have assembled an interdisciplinary research team and prepared innovative techniques (super-resolution microscopy, single-cell RNAseq, ATACseq) that, combined with cardiomyocyte-specific Lmnb2flox inactivation and viral expression of Lmnb2, will enable us to determine its role in nuclear remodeling in cardiomyocyte differentiation. The anticipated results will enable future research toward understanding and targeting nuclear remodeling in myocardial development, regeneration, and disease. This will be broadly significant for patients with congenital and acquired heart diseases.
摘要 心脏病是世界范围内发病率和死亡率的主要原因。不同类型的心脏损伤会导致 心力衰竭是一种慢性进行性疾病。心力衰竭的特征是 心肌细胞死亡和新生心肌再生不足。因此,增加心肌细胞 再生和减少死亡是新疗法的目标。此应用程序用于开发 将这些重要的细胞机制与核重塑联系起来的变革性范式 心肌细胞分化。 我们的新结果表明,当心肌细胞分化时,它们减少了细胞核的数量 毛孔(Np)。NP是外径为100 nm的大通道,用于核和核之间的通信 细胞质。NP与核膜(NL)一起在调节信号的核运输方面起作用 分子和染色质组织。尽管心力衰竭改变了核运输,但结构和 NL和NP在终末分化过程中的功能变化尚不清楚。要确定 指导NP减少的分子机制,我们使用了单细胞转录图谱,这是 确定层蛋白B2(Lmnb2)的表达减少,Lmnb2是NL的中间丝和成分, 在心肌细胞分化过程中。我们的新结果表明,Lmnb2基因在心肌细胞中被敲除 阻断M期,也就是细胞核不分裂,而变成多倍体。此外,M相块 减少NP的掺入。因此,虽然细胞核(倍体)的DNA含量增加,但 NP下降50%。较低的NP数字标识了核重构的中心事件,正如它所表明的那样 不仅改变了核运输,还改变了染色质结构。总而言之,这可以解释 终末分化心肌细胞激活细胞周期基因的能力降低和增强 对细胞死亡易感性。 这一建议旨在发展一种新的心肌细胞核重塑的机制范式。 分化,这与最近在表征染色质变化方面的进展是协同的。我们将测试 中心假说认为Lmnb2基因表达减少是核的中心机制 心肌细胞分化中的重塑。我们已经组建了一个跨学科的研究团队, 准备了创新技术(超分辨率显微镜、单细胞RNAseq、ATACseq),结合 通过心肌细胞特异性Lmnb2flx的失活和Lmnb2的病毒表达,将使我们能够确定其 核重塑在心肌细胞分化中的作用。 预期的结果将使未来的研究能够理解和瞄准核 心肌发育、再生和疾病中的重塑。这将对患者具有广泛的意义 患有先天性和获得性心脏病。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Bernhard Kuhn其他文献

Bernhard Kuhn的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Bernhard Kuhn', 18)}}的其他基金

Mechanistic clinical trial of β-blocker administration for reactivating cardiomyocyte division in Tetralogy of Fallot
法洛四联症中β受体阻滞剂重新激活心肌细胞分裂的机制临床试验
  • 批准号:
    10427418
  • 财政年份:
    2021
  • 资助金额:
    $ 32.76万
  • 项目类别:
Mechanistic clinical trial of β-blocker administration for reactivating cardiomyocyte division in Tetralogy of Fallot
法洛四联症中β受体阻滞剂重新激活心肌细胞分裂的机制临床试验
  • 批准号:
    10630817
  • 财政年份:
    2021
  • 资助金额:
    $ 32.76万
  • 项目类别:
Mechanistic clinical trial of β-blocker administration for reactivating cardiomyocyte division in Tetralogy of Fallot
法洛四联症中β受体阻滞剂重新激活心肌细胞分裂的机制临床试验
  • 批准号:
    10840490
  • 财政年份:
    2021
  • 资助金额:
    $ 32.76万
  • 项目类别:
Mechanistic clinical trial of β-blocker administration for reactivating cardiomyocyte division in Tetralogy of Fallot
法洛四联症中β受体阻滞剂重新激活心肌细胞分裂的机制临床试验
  • 批准号:
    10295053
  • 财政年份:
    2021
  • 资助金额:
    $ 32.76万
  • 项目类别:
Lamin B2 regulates nuclear remodeling in cardiomyocyte terminal differentiation
Lamin B2 调节心肌细胞终末分化中的核重塑
  • 批准号:
    10372035
  • 财政年份:
    2020
  • 资助金额:
    $ 32.76万
  • 项目类别:
Quantification of the decline of heart muscle cell proliferation and its reversal in pediatric patients
儿科患者心肌细胞增殖下降及其逆转的量化
  • 批准号:
    10413070
  • 财政年份:
    2020
  • 资助金额:
    $ 32.76万
  • 项目类别:
Quantification of the decline of heart muscle cell proliferation and its reversal in pediatric patients
儿科患者心肌细胞增殖下降及其逆转的量化
  • 批准号:
    10625836
  • 财政年份:
    2020
  • 资助金额:
    $ 32.76万
  • 项目类别:
Quantification of the decline of heart muscle cell proliferation and its reversal in pediatric patients
儿科患者心肌细胞增殖下降及其逆转的量化
  • 批准号:
    10191031
  • 财政年份:
    2020
  • 资助金额:
    $ 32.76万
  • 项目类别:
Myofibril disassembly during neonatal heart muscle cell proliferation
新生儿心肌细胞增殖过程中的肌原纤维解体
  • 批准号:
    8780671
  • 财政年份:
    2010
  • 资助金额:
    $ 32.76万
  • 项目类别:
Myofibril disassembly during neonatal heart muscle cell proliferation
新生儿心肌细胞增殖过程中的肌原纤维解体
  • 批准号:
    8386967
  • 财政年份:
    2010
  • 资助金额:
    $ 32.76万
  • 项目类别:

相似海外基金

Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
  • 批准号:
    23K09542
  • 财政年份:
    2023
  • 资助金额:
    $ 32.76万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The impact of changes in social determinants of health on adolescent and young adult mental health during the COVID-19 pandemic: A longitudinal study of the Asenze cohort in South Africa
COVID-19 大流行期间健康社会决定因素的变化对青少年和年轻人心理健康的影响:南非 Asenze 队列的纵向研究
  • 批准号:
    10755168
  • 财政年份:
    2023
  • 资助金额:
    $ 32.76万
  • 项目类别:
A Priority Setting Partnership to Establish a Patient, Caregiver, and Clinician-identified Research Agenda for Adolescent and Young Adult Cancer in Canada
建立优先合作伙伴关系,以建立患者、护理人员和临床医生确定的加拿大青少年和年轻人癌症研究议程
  • 批准号:
    480840
  • 财政年份:
    2023
  • 资助金额:
    $ 32.76万
  • 项目类别:
    Miscellaneous Programs
Incidence and Time on Onset of Cardiovascular Risk Factors and Cardiovascular Disease in Adult Survivors of Adolescent and Young Adult Cancer and Association with Exercise
青少年和青年癌症成年幸存者心血管危险因素和心血管疾病的发病率和时间以及与运动的关系
  • 批准号:
    10678157
  • 财政年份:
    2023
  • 资助金额:
    $ 32.76万
  • 项目类别:
Fertility experiences among ethnically diverse adolescent and young adult cancer survivors: A population-based study
不同种族青少年和年轻成年癌症幸存者的生育经历:一项基于人群的研究
  • 批准号:
    10744412
  • 财政年份:
    2023
  • 资助金额:
    $ 32.76万
  • 项目类别:
Treatment development for refractory leukemia using childhood/adolescent, and young adult leukemia biobank
利用儿童/青少年和青年白血病生物库开发难治性白血病的治疗方法
  • 批准号:
    23K07305
  • 财政年份:
    2023
  • 资助金额:
    $ 32.76万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Molecular design of Two-Way Player CAR-T cells to overcome disease/antigen heterogeneity of childhood, adolescent, and young adult cancers
双向 CAR-T 细胞的分子设计,以克服儿童、青少年和年轻成人癌症的疾病/抗原异质性
  • 批准号:
    23H02874
  • 财政年份:
    2023
  • 资助金额:
    $ 32.76万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Effects of adolescent social isolation on adult decision making and corticostriatal circuitry
青少年社会隔离对成人决策和皮质纹状体回路的影响
  • 批准号:
    10756652
  • 财政年份:
    2023
  • 资助金额:
    $ 32.76万
  • 项目类别:
Adolescent trauma produces enduring disruptions in sleep architecture that lead to increased risk for adult mental illness
青少年创伤会对睡眠结构产生持久的破坏,从而导致成人精神疾病的风险增加
  • 批准号:
    10730872
  • 财政年份:
    2023
  • 资助金额:
    $ 32.76万
  • 项目类别:
Using Tailored mHealth Strategies to Promote Weight Management among Adolescent and Young Adult Cancer Survivors
使用量身定制的移动健康策略促进青少年和年轻癌症幸存者的体重管理
  • 批准号:
    10650648
  • 财政年份:
    2023
  • 资助金额:
    $ 32.76万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了